Predicting Persistent Left Ventricular Dysfunction After Cardiac Resynchronization Therapy Upgrade in Pacing-Induced Cardiomyopathy
Journal of Clinical Medicine · 09.11.2026 · 15 (21) · 8731
DOI: 10.3390/jcm15218731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.11.2026. Verfasst von Jakub Simka und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine Cardiology and Angiology, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charles University.
Abstract (Originalsprache)
Background/Objectives: Pacing-induced cardiomyopathy (PICM) is potentially reversible after cardiac resynchronization therapy (CRT) upgrade, but severe left ventricular dysfunction persists in some patients. We evaluated predictors of persistent left ventricular ejection fraction (LVEF) ≤ 35% after CRT upgrade and long-term outcomes.
Methods
We analysed 60 patients undergoing CRT upgrade for PICM. The primary outcome was persistent LVEF ≤ 35% at 12 months. Clinical, electrocardiographic, echocardiographic, and long-term outcomes were assessed.
Results
At 12 months, median LVEF increased from 30% to 45% (p < 0.01), and 82% of patients recovered to an LVEF > 35%. Persistent severe left ventricular dysfunction was associated with lower baseline LVEF (22% vs. 30%; p < 0.01), greater left ventricular end-diastolic diameter (LVEDD) (65 mm vs. 58 mm; p = 0.03), and longer post-CRT QRS duration (154 ms vs. 140 ms; p = 0.02); none remained independently significant after multivariable adjustment. No patient with baseline LVEF > 25% and LVEDD < 65 mm had persistent severe LV dysfunction, compared with 46% of those with LVEF ≤ 25% and LVEDD ≥ 65 mm. In the 12-month landmark analysis, mortality through 60 months after CRT upgrade was 55% in patients with persistent severe LV dysfunction and 31% in those with LVEF recovery.
Conclusions
CRT upgrade was associated with substantial recovery of LV systolic function in patients with PICM. Severe baseline LV dysfunction and LV dilatation were associated with a lower likelihood of recovery to an LVEF > 35%. These exploratory findings may aid risk stratification but require prospective validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Department of Internal Medicine Cardiology and Angiology, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.
- Faculty of Medicine in Hradec Kralove, Charles University, 500 03 Hradec Kralove, Czech Republic.
ORCID-Profile: Jakub Simka, Eva Cermakova, Jakub Stritecky, Ludek Haman
Förderung
- Charles University
Zitieren
APA
Simka, J., Praus, R., Jager, J., Matatko, M., Fialova, M., Cermakova, E., Stritecky, J., Haman, L., & Parizek, P. (2026). Predicting Persistent Left Ventricular Dysfunction After Cardiac Resynchronization Therapy Upgrade in Pacing-Induced Cardiomyopathy. Journal of Clinical Medicine, 15(21), 8731. https://doi.org/10.3390/jcm15218731
Vancouver
Simka J, Praus R, Jager J, Matatko M, Fialova M, Cermakova E, et al. Predicting Persistent Left Ventricular Dysfunction After Cardiac Resynchronization Therapy Upgrade in Pacing-Induced Cardiomyopathy. Journal of Clinical Medicine. 2026;15(21):8731. doi:10.3390/jcm15218731
BibTeX
@article{Simka2026,
author = {Simka, Jakub and Praus, Rudolf and Jager, Jiri and Matatko, Martin and Fialova, Monika and Cermakova, Eva and Stritecky, Jakub and Haman, Ludek and Parizek, Petr},
title = {Predicting Persistent Left Ventricular Dysfunction After Cardiac Resynchronization Therapy Upgrade in Pacing-Induced Cardiomyopathy},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8731},
doi = {10.3390/jcm15218731}
}
EUVIMED